REQUEST A DEMO
Total
USD $0.00
Search more companies

Sm Pharmaceuticals Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Sm Pharmaceuticals Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sm Pharmaceuticals Sdn. Bhd. is based in Malaysia. The head office is in Sungai Petani. It operates in the Medicinal and Botanical Manufacturing industry. It was established on June 12, 1991. There are currently 150 (2023) people employed by Sm Pharmaceuticals Sdn. Bhd.. In 2023, the company reported a net sales revenue increase of 5.22%. Over the same period, its total assets grew by 4.43%. The net profit margin of Sm Pharmaceuticals Sdn. Bhd. decreased by 2.54% in 2023.

Headquarters
Lot 88, Sungai Petani Industrial Estate
Sungai Petani; Kedah; Postal Code: 08000

Contact Details: Purchase the Sm Pharmaceuticals Sdn. Bhd. report to view the information.

Website: http://www.smpharmaceutic.com

Basic Information
Total Employees:
Purchase the Sm Pharmaceuticals Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Sm Pharmaceuticals Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Sm Pharmaceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Sm Pharmaceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
June 12, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sm Pharmaceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
5.22%
Total operating revenue
5.22%
Operating profit (EBIT)
-22.85%
EBITDA
-15.97%
Net Profit (Loss) for the Period
-21.97%
Total assets
4.43%
Total equity
2.97%
Operating Profit Margin (ROS)
-3.36%
Net Profit Margin
-2.54%
Return on Equity (ROE)
-2.9%
Debt to Equity Ratio
-1.23%
Quick Ratio
-0.21%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?